GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » EBITDA Margin %

Tauns Laboratories (TSE:197A) EBITDA Margin % : 46.34% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tauns Laboratories's EBITDA for the six months ended in Jun. 2024 was 円8,542 Mil. Tauns Laboratories's Revenue for the six months ended in Jun. 2024 was 円18,435 Mil. Therefore, Tauns Laboratories's EBITDA margin for the quarter that ended in Jun. 2024 was 46.34%.


Tauns Laboratories EBITDA Margin % Historical Data

The historical data trend for Tauns Laboratories's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories EBITDA Margin % Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
EBITDA Margin %
48.99 33.92 46.34

Tauns Laboratories Semi-Annual Data
Jun22 Jun23 Jun24
EBITDA Margin % 48.99 33.92 46.34

Competitive Comparison of Tauns Laboratories's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's EBITDA Margin % falls into.



Tauns Laboratories EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tauns Laboratories's EBITDA Margin % for the fiscal year that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=8542.065/18434.863
=46.34 %

Tauns Laboratories's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=8542.065/18434.863
=46.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tauns Laboratories  (TSE:197A) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Tauns Laboratories EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines